Healthcare
Nihon Kohden Corporation(NHNKY)
Live Price
Offline$8.57
+0.54% today
1Y Change
-32.04%
Window
Jun 25, 2025 โ Jun 18, 2026
- Market Cap
- $234.25B
- Revenue Growth
- +1.5%
- EPS Growth
- -16.1%
- Dividend Yield
- 2.2%
Coverage: 247 bars ยท Jun 25, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Nihon Kohden Corporation (NHNKY) is a Healthcare stock with a market cap of $234.25B and listed on OTC. The stock last traded around $8.57 and down 32.0% across the available one-year price window (Jun 25, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +1.5%, EPS growth of -16.1%, a dividend yield of 2.2%. What stands out right now is revenue +1.5%, EPS -16.1%, free cash flow -39.2% with operating margin 8.2% and ROIC 6.4%. The dividend is present but secondary, with a yield around 2.2%. Valuation is more restrained than many high-expectation growth names at P/E 19.0 and price/sales 1.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines NHNKY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+1.5% vs +7.6% peer median
Operating Margin
Below sector median
+8.2% vs +19.4% peer median
P/E
Below sector median
19.0 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 11, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +1.5% and EPS is at -16.1%, with operating margin around 8.2%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 2.2%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -2.4% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 11, 2026 | โ | -2.4% | +1.2% | -6.9% |
2026 Feb 5, 2026 | โ | -9.6% | -4.1% | -18.0% |
2025 Nov 10, 2025 | โ | -3.2% | -4.3% | -6.2% |
Benchmark Edge
NHNKY vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
NHNKY
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
NHNKY Max Drawdown
-41.94%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for NHNKY and SPY.
Company Overview
Nihon Kohden Corporation
Other OTC
Nihon Kohden Corporation engages in research and development, production, sale, repair, and maintenance of medical electronic equipment in Japan, Americas, Europe, rest of Asia, and internationally. The company offers physiological measuring equipment, including electroencephalographs, electrocardiographs, evoked potential and electromyogram measuring instruments, and polygraphs for cath labs, as well as diagnostic information systems and related consumables, such as recording papers, electrodes and catheters, and maintenance services. It also provides patient monitors systems comprising central monitors, bedside monitors, wireless monitors, remote access software, and other equipment; and clinical information systems and related consumables, such as electrodes and sensors. In addition, the company offers treatment equipment, which include defibrillators, automated external defibrillators (AED), ventilators, pacemakers, anesthesia machines, cochlear implants, and related consumables and services, which include AED pads and batteries; and other medical equipment, including hematology and clinical chemistry analyzers, ultrasound diagnostic equipment, and equipment for research and others, as well as consumables, including test reagents, and installation and maintenance services. Additionally, it engages in insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Tokyo, Japan.
- Leadership
- Hirokazu Ogino
- IPO Date
- Sep 27, 2013
- Employees
- 5.9k
- Street Address
- 1-31-4 Nishiochiai
- Mailing
- Tokyo, 161-8560
- Region
- Tokyo, JP
- Reporting Currency
- USD
- Investor Line
- 81 3 5996 8036
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 19.0
- EV/EBITDA
- 9.1
- Price/Sales
- 1.0
- Price/Book
- 1.4
Growth
- Revenue
- +1.5%
- EPS
- -16.1%
- Free Cash Flow
- -39.2%
Profitability
- Gross Margin
- 51.9%
- Operating Margin
- 8.2%
- Net Margin
- 5.4%
- ROE
- 7.1%
- ROIC
- 6.4%
Balance Sheet
- Debt/Equity
- 0.15
- Current Ratio
- 3.64
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.